Breast Cancer Clinical Trial
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Summary
Risks from imaging-related radiation exposure have become a popular topic in the media. Because these tests are commonly applied to patients at a cancer center, it is important to understand what patients know, how they feel about what they know, where they get their information, and how satisfied they are with available risk-benefit communication on this topic.
The purpose of this study is to understand how cancer patients perceive risks and benefits of diagnostic radiation and their satisfaction with healthcare communication on this topic.
Eligibility Criteria
Inclusion Criteria:
English-language fluent
18 years of age, or older
Provide informed consent
Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma.
Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3 neuroblastoma.
Group 3: Women who have undergone treatment for early stage breast cancer within the preceding 6 months.
Group 4: Men undergoing surveillance imaging after treatment for testicular cancer.
Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening program.
Group 6: Patients enrolled in or eligible for the thoracic survivorship program.
Exclusion Criteria:
Participants who don't speak English
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10065, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.